Bortezomib and thalidomide for the first‑line treatment of multiple myeloma

  • Technology appraisal guidance
  • TA228
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that bortezomib and thalidomide are recommended as options for treating multiple myeloma.

ISBN: 978-1-4731-6681-3